FDA Approves ADRENALIN — Par Health USA, LLC

On December 7, 2012, Par Health USA, LLC received FDA approval for its NDA for ADRENALIN (epinephrine) 1 mg/mL intramuscular injection, a generic equivalent expected to provide an alternative to the original brand name product and potentially broaden market supplier channels.